SecureBio
- Company typePrivate
- Founded-
- HeadquartersCambridge, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
SecureBio firmographics
Firmographics- Name
- SecureBio
- Legal name
- SecureBio, Inc
- Website
- https://securebio.org
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
SecureBio industry classification
Industry- Product category
- Biosecurity Software & Research
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Computer Systems Design and Related Services (54151), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)
Keywords
Where SecureBio is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
SecureBio business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Donations and Grants: SecureBio is a federally registered 501(c)(3) non-profit organization (EIN 88-3068255). The organization relies on donations for funding, with donations from US residents being tax-deductible. UK and EU donors may contact the organization for potential tax-deductible donation options.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
SecureBio product offering
Product offeringCore offering
SecureBio develops pathogen-agnostic early-warning systems for pandemics using deep, untargeted metagenomic sequencing (SecureBio Detection), builds free DNA synthesis screening software (SecureDNA), and creates evaluation benchmarks and tools to measure AI systems' potential to exacerbate biological risks (BioTIER, Virology Capabilities Test, AI Benchmarks Dashboard). The organization is a 501(c)(3) nonprofit that collaborates with academia, industry, and government on technologies and policy proposals across three pillars: Delay, Detect, and Defend against catastrophic pandemics.
Product overview
SecureBio is a biosecurity nonprofit offering a portfolio of products focused on pandemic prevention through three pillars: Delay, Detect, and Defend. The core Detection platform (SecureBio Detection, formerly Nucleic Acid Observatory) provides pathogen-agnostic early warning through deep metagenomic sequencing. Supporting tools include SecureDNA for DNA synthesis screening, BioTIER for AI biotechnology risk evaluation, and the Virology Capabilities Test benchmark. The AI Benchmarks Dashboard tracks frontier model performance on biosecurity-relevant biology tasks. SecureBio also offers research resources including MGS Data tools and maintains partnerships with major AI developers to improve oversight of frontier AI models.
Differentiator
Problem solved
Functional benefit
Brands
- SecureBio Detection: Detection project focused on pioneering reliable, pathogen-agnostic early warning of future pandemics through deep, untargeted metagenomic sequencing (formerly known as Nucleic Acid Observatory)
- BioTIER
- CASPER
- Zephyr
- SecureDNA
Products and services
- SecureBio Detection Pathogen-agnostic early warning of future pandemics through deep, untargeted metagenomic sequencing; detects new and unknown pathogens including those with long incubation times. Aimed at biosurveillance programs, public health agencies, and pandemic preparedness efforts.
- SecureDNA
Quantifiable outcome
- Leading AI models perform at or above human-expert level on most biology benchmarks since 2024, including troubleshooting laboratory experiments, designing DNA sequences for working with viral pathogens, and writing code to drive protein-design tools
- +1 more outcomes
Companies that use SecureBio
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
SecureBio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature7 records
SecureBio partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core, flagship and minor.
- NIST US AI Safety ConsortiumcoreSecureBio is a member of the NIST US AI Safety Consortium, working to improve oversight of frontier AI models through technology and policy collaborations focused on biosecurity risks.
- European AI OfficecoreSecureBio is a partner to the European AI Office, collaborating on AI safety and biosecurity oversight at the European level.
- SecureDNAflagshipSecureDNA was founded as a collaboration between academics and developers in the US, China and Europe. It has recently been spun out into an independent Swiss foundation providing free, privacy-preserving, and politically-neutral DNA synthesis screening services worldwide.
- OpenAIcoreSecureBio works with OpenAI on AI biosecurity evaluations and mitigation strategies, assessing the potential for AI systems to contribute to biological risks and developing safeguards.
- AnthropiccoreSecureBio collaborates with Anthropic on biosecurity evaluations and has worked with them on developing mitigations for AI-enabled biological risks.
- MetacoreSecureBio works with Meta on AI biosecurity evaluations and understanding misuse risks from frontier AI models.
- xAIcoreSecureBio collaborates with xAI on biosecurity-relevant AI capability evaluations and mitigation strategies.
- Scale AIminorSecureBio has worked with Scale AI on AI safety and biosecurity initiatives.
- CAISI (Center for AI Safety)coreSecureBio partners with CAISI on AI safety evaluations and biosecurity research.
- Future of Life InstituteminorSecureBio collaborates with the Future of Life Institute on AI safety and biosecurity topics.
- Academia and Government ExpertscoreSecureBio's in-house team of researchers and technologists work with experts across academia, industry and government to develop new technologies and policy proposals for pandemic preparedness.
Scale indicators3 records
Recent moves8 records
Expansion highlights5 records
SecureBio competitors and assessment
Company assessmentBroad incumbents
- Future of Life Institute: Larger, older AI safety non-profit focused on policy advocacy and grants around catastrophic risks including biosecurity. Comparable as a fellow biosecurity/AI safety non-profit partner of SecureBio, but with a broader policy-advocacy remit rather than technical evaluation work.
- BlueDot: Canadian firm providing infectious disease intelligence and pandemic early warning using data analytics. Comparable to SecureBio Detection as an outbreak-detection platform, but commercially operated and target-focused on known pathogens.
- bioMérieux (BioFire Diagnostics): Major diagnostics company operating the BioFire FilmArray syndromic pathogen detection panels. Comparable as a pathogen-detection organization operating at scale; much larger, commercially focused on targeted clinical diagnostics rather than pathogen-agnostic sequencing.
- Metabiota: Pandemic risk analytics and biosurveillance company. Comparable to SecureBio's Detection pillar as a pathogen-monitoring organization, but operating commercially with insurer and government clients rather than as a non-profit research effort.
Direct peers
- SecureDNA Foundation: Independent Swiss foundation that was incubated at SecureBio. Directly comparable as a SecureBio spin-out providing free DNA synthesis screening software — same mission (delay biothreats), same funding model (non-profit), same target customers (DNA synthesis providers globally).
- Convergent Research: Operator of focused research organizations (FROs) including Arc Institute. Highly comparable operating model to SecureBio — small, talent-dense, mission-driven non-profit labs producing scientific and technological outputs aimed at high-impact problems.
- METR (Model Evaluation and Threat Research): Non-profit that builds rigorous evaluations of frontier AI capabilities. Comparable to SecureBio as a mission-aligned evaluation shop; the focus is autonomy/cyber rather than biosecurity, but the customer base (OpenAI, Anthropic, UK/US AI Safety Institutes) and operating model overlap closely.
- Apollo Research: AI safety evaluation organization that conducts rigorous capability and risk evaluations of frontier AI models. Directly comparable to SecureBio's BioTIER/VCT work: both are small, focused research orgs producing trusted third-party evaluations used by major AI labs and governments.
- Center for AI Safety (CAISI): Berkeley-based research org focused on AI existential risk. Listed as a SecureBio partner; directly comparable as a small, talent-dense AI safety research non-profit producing influential research used by frontier labs and policymakers.
Regional players
- UK AI Security Institute (AISI): UK government body conducting pre- and post-deployment evaluations of frontier AI models including bio-risk. Comparable to SecureBio as a biosecurity evaluator for frontier AI; operates as a government body primarily serving UK/UK-allied regulators rather than as a non-profit serving all model developers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
SecureBio social profiles
Digital presenceSecureBio compliance and trust
Trust signalCompliance1 record
SecureBio financial estimates
Financial estimateRevenue estimate
Valuation estimate
SecureBio leadership team
Management profileNumber of profiles
Profiles1 record
SecureBio subsidiaries and ownership
Company hierarchySubsidiaries1 record
SecureBio funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SecureBio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SecureBio
What does SecureBio do?
SecureBio develops pathogen-agnostic early-warning systems for pandemics using deep, untargeted metagenomic sequencing (SecureBio Detection), builds free DNA synthesis screening software (SecureDNA), and creates evaluation benchmarks and tools to measure AI systems' potential to exacerbate biological risks (BioTIER, Virology Capabilities Test, AI Benchmarks Dashboard). The organization is a 501(c)(3) nonprofit that collaborates with academia, industry, and government on technologies and policy proposals across three pillars: Delay, Detect, and Defend against catastrophic pandemics.
Is SecureBio a public or private company?
SecureBio is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was SecureBio founded?
SecureBio was founded in -1. It employs 11 to 50 people.
Where is SecureBio based?
SecureBio is headquartered in Cambridge, United States, in the North America region.
How does SecureBio make money?
One revenue line is on record: donations and Grants.
Who are SecureBio's main competitors?
Broad incumbents on record are Future of Life Institute, BlueDot, bioMérieux (BioFire Diagnostics) and Metabiota. Direct peers are SecureDNA Foundation, Convergent Research, METR (Model Evaluation and Threat Research), Apollo Research and Center for AI Safety (CAISI). UK AI Security Institute (AISI) is listed as a regional player.
Does SecureBio have an API?
No public API is recorded for SecureBio.
What industry is SecureBio in?
SecureBio's product category is Biosecurity Software & Research. Its primary akta.pro industry code is HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms. Its NAICS code is 541714 and its SIC code is 7372.